Bristol-Myers Squibb Stock (BMY) News, Forecasts and Analysis for Dec. 12, 2025: Dividend Hike, FDA Updates, and Wall Street’s 2026 Focus
Bristol-Myers Squibb shares rose 2.5% to $52.50 by mid-day Friday after Guggenheim upgraded the stock to Buy with a $62 target. The company announced a 1.6% dividend increase to $0.63 per share, its 17th consecutive annual raise. The FDA granted Priority Review for Opdivo in Hodgkin lymphoma, and approved Breyanzi for marginal zone lymphoma earlier this month.